223 related articles for article (PubMed ID: 36485129)
1. Knowledge to date on secondary malignancy following hematopoietic cell transplantation for sickle cell disease.
Fitzhugh CD
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):266-271. PubMed ID: 36485129
[TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
3. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
[TBL] [Abstract][Full Text] [Related]
4. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
[TBL] [Abstract][Full Text] [Related]
5. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation.
Kean LS; Durham MM; Adams AB; Hsu LL; Perry JR; Dillehay D; Pearson TC; Waller EK; Larsen CP; Archer DR
Blood; 2002 Mar; 99(5):1840-9. PubMed ID: 11861303
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic Transplant and Gene Therapy: Evolving Toward a Cure.
Lawal RA; Walters MC; Fitzhugh CD
Hematol Oncol Clin North Am; 2022 Dec; 36(6):1313-1335. PubMed ID: 36400545
[TBL] [Abstract][Full Text] [Related]
7. The range of haploidentical transplant protocols in sickle cell disease: all haplos are not created equally.
Kassim AA; DeBaun MR
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):532-541. PubMed ID: 38066894
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease.
Inam Z; Tisdale JF; Leonard A
Expert Rev Hematol; 2023; 16(11):879-903. PubMed ID: 37800996
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.
Hsieh MM; Kang EM; Fitzhugh CD; Link MB; Bolan CD; Kurlander R; Childs RW; Rodgers GP; Powell JD; Tisdale JF
N Engl J Med; 2009 Dec; 361(24):2309-17. PubMed ID: 20007560
[TBL] [Abstract][Full Text] [Related]
11. Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
Devadasan D; Sun CW; Westin ER; Wu LC; Pawlik KM; Townes TM; Goldman FD
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1554-1562. PubMed ID: 29684562
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients.
Damlaj M; Alahmari B; Alaskar A; Alhejazi A; Alsadi H; Ahmed M; Alanazi T; Ahmed R; Alharbi A; Shehabeddine I; Alzaidi A; Alkhuraisat S; Mahassnah I; Alquraan H; Ballili M; Alzahrani M
Am J Hematol; 2024 Jun; 99(6):1023-1030. PubMed ID: 38488686
[TBL] [Abstract][Full Text] [Related]
13. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
[TBL] [Abstract][Full Text] [Related]
14. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.
Strocchio L; Zecca M; Comoli P; Mina T; Giorgiani G; Giraldi E; Vinti L; Merli P; Regazzi M; Locatelli F
Br J Haematol; 2015 Jun; 169(5):726-36. PubMed ID: 25818248
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
[TBL] [Abstract][Full Text] [Related]
16. Allogenic hematopoietic stem cell transplantation in sickle cell disease.
Furstenau DK; Tisdale JF
Transfus Apher Sci; 2021 Feb; 60(1):103057. PubMed ID: 33485798
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.
Mielcarek M; Kirkorian AY; Hackman RC; Price J; Storer BE; Wood BL; Leboeuf M; Bogunovic M; Storb R; Inamoto Y; Flowers ME; Martin PJ; Collin M; Merad M
Transplantation; 2014 Sep; 98(5):563-8. PubMed ID: 24717220
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
Talano JA; Cairo MS
Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
[TBL] [Abstract][Full Text] [Related]
20. CD34
Barba P; Martino R; Zhou Q; Cho C; Castro-Malaspina H; Devlin S; Esquirol A; Giralt S; Jakubowski AA; Caballero D; Maloy M; Papadopoulos EB; Piñana JL; Fox ML; Márquez-Malaver FJ; Valcárcel D; Solano C; López-Corral L; Sierra J; Perales MA
Biol Blood Marrow Transplant; 2018 May; 24(5):964-972. PubMed ID: 29305194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
